Filing Details
- Accession Number:
- 0001140361-12-043250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-09 16:43:29
- Reporting Period:
- 2012-10-03
- Filing Date:
- 2012-10-09
- Accepted Time:
- 2012-10-09 16:43:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
788920 | Pro Dex Inc | PDEX | Surgical & Medical Instruments & Apparatus (3841) | 841261240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1478067 | John Nicholas Swenson | 3033 Excelsior Boulevard, Suite 560 Minneapolis MN 55416 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-10-03 | 300 | $1.79 | 45,244 | No | 4 | L | Indirect | By AO Partners I, LP |
Common Stock | Acquisiton | 2012-10-03 | 186 | $1.75 | 45,430 | No | 4 | L | Indirect | By AO Partners I, LP |
Common Stock | Acquisiton | 2012-10-05 | 6,743 | $1.89 | 52,173 | No | 4 | P | Indirect | By AO Partners I, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | L | Indirect | By AO Partners I, LP |
No | 4 | L | Indirect | By AO Partners I, LP |
No | 4 | P | Indirect | By AO Partners I, LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 172,271 | Indirect | By Glenhurst Co. |
Common Stock | 257,506 | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.86 to $1.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.